Use in pregnancy: There are no adequate data from the use of ranolazine in pregnant women. Animal studies are insufficient with respect to effects on pregnancy and embryofetal development. The potential risk for humans is unknown. Ranexa should not be used during pregnancy unless clearly necessary.
Use in lactation: It is unknown whether ranolazine is excreted in human breast milk. The excretion of ranolazine in milk has not been studied in animals. Ranexa should not be used during breastfeeding.
Other Services
Country
Account